Follow me on X. @sangngqang
포뮬라인 Formula:in logo

Is 포뮬라인 Formula:in legit?

formula-in.com

Our check

포뮬라인 Formula:in gets about 64K visits a month (SimilarWeb, Oct 2026). The store was created in Sep 2023, 3 years ago, and is based in South Korea.

Checked . Facts only, from the Meta Ad Library, SimilarWeb, Trustpilot and the store itself; anything we have not measured is left out.

Shopper reviews

No one has reviewed 포뮬라인 Formula:in here yet. Be the first to say how your order went.

Bought from 포뮬라인 Formula:in?

Tell other shoppers how it went. It takes a minute.

Write a review

Questions shoppers ask

Is 포뮬라인 Formula:in legit?
포뮬라인 Formula:in gets about 64K visits a month (SimilarWeb, Oct 2026). The store was created in Sep 2023, 3 years ago, and is based in South Korea. These are measured facts, not a rating; check the flags on this page before you buy.
Where is 포뮬라인 Formula:in based?
formula-in.com is registered as a store in South Korea.
How much traffic does formula-in.com get?
formula-in.com had 63,538 visits in Oct 2026, as measured by SimilarWeb for this exact host. That is up 55% on the month before. 포뮬라인 Formula:in traffic and size
How much revenue does 포뮬라인 Formula:in make?
포뮬라인 Formula:in does not publish its revenue and no source AdLibrarySpy holds measures it, so no revenue figure is shown. Its measured size signals are 63,538 visits in Oct 2026 (SimilarWeb) and 2 products. How big is 포뮬라인 Formula:in?
Who are 포뮬라인 Formula:in's competitors?
포뮬라인 Formula:in's closest competitors in the AdLibrarySpy index, by niche and traffic, are 동국제약 공식 건강몰 (dknutrition.co.kr), 바르통 (var-ton.com), 오늘부터 (fromtoday.kr), BARC 바크 (barc.co.kr) and 메디온 (themedion.com). Sites like 포뮬라인 Formula:in
See every ad 포뮬라인 Formula:in runs

Its full Meta ad history, the products it pushes and where it advertises — free, no card.

See the ads free

Similar brands checked

Research any store: see its live ads, its apps & pixels, and estimate its scale. Shopping safely: how to tell if a store is legit and how to avoid shopping scams.